|
| |
| | | 66172 | | 20.10.2017 | | Basilea Pharmaceutica International AG, Allschwil | | | | | | | | | | | | | 80000. | | | | 08.06. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Cresemba 100 mg | Hartkapseln | Capsules (Isavuconazonium 100 mg) | J02AC05 | CI | | 02 | Cresemba 40 mg | Hartkapseln | Capsules (Isavuconazonium 40 mg) | J02AC05 | CI |
|
|
|
